Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition(s):Pulmonary TuberculosisLast Updated:December 5, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Pulmonary TuberculosisLast Updated:December 5, 2019Unknown status
Condition(s):Tuberculosis; HIVLast Updated:October 27, 2017Completed
Condition(s):Tuberculosis; PulmonaryLast Updated:July 22, 2021Unknown status
Condition(s):Pulmonary TuberculosisLast Updated:August 7, 2020Unknown status
Condition(s):HIV-1 InfectionLast Updated:October 19, 2020Completed
Condition(s):Pulmonary TuberculosisLast Updated:March 23, 2020Completed
Condition(s):Tuberculosis, Pulmonary, Drug Sensitive; Tuberculosis, Pulmonary, Multi Drug-resistantLast Updated:March 26, 2019Completed
Condition(s):Pulmonary TuberculosisLast Updated:April 19, 2021Completed
Condition(s):TuberculosisLast Updated:June 8, 2021Completed
Condition(s):TuberculosisLast Updated:September 9, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.